The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Centessa Pharmaceuticals plc ADR shares valued at $4,354 were sold by HUSSAIN IQBAL J on May 01 ’25. At $14.00 per share, HUSSAIN IQBAL J sold 311 shares. The insider’s holdings dropped to 105,386 shares worth approximately $1.33 million following the completion of this transaction.
Also, HUSSAIN IQBAL J sold 3,609 shares, netting a total of over 50,526 in proceeds. Following the sale of shares at $14.00 each, the insider now holds 105,386 shares.
Before that, HUSSAIN IQBAL J had sold 2,080 shares from its account. In a trade valued at $29,132, the General Counsel traded Centessa Pharmaceuticals plc ADR shares for $14.01 each. Upon closing the transaction, the insider’s holdings decreased to 2,080 shares, worth approximately $1.33 million.
As published in their initiating research note from Chardan Capital Markets on May 08, 2025, Centessa Pharmaceuticals plc ADR [CNTA] has been a Buy and the price target has been revised to $30. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in late March. As of January 07, 2025, TD Cowen has initiated its “Buy” rating for CNTA. Earlier on September 20, 2024, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for CNTA stock which previously was a “an Equal-weight”.
Analyzing CNTA Stock Performance
During the last five days, there has been a surge of approximately 1.61%. Over the course of the year, Centessa Pharmaceuticals plc ADR shares have dropped approximately -24.84%. Shares of the company reached a 52-week high of $19.09 on 02/07/25 and a 52-week low of $9.60 on 04/09/25. A 50-day SMA is recorded $13.84, while a 200-day SMA reached $15.18.
Support And Resistance Levels for Centessa Pharmaceuticals plc ADR (CNTA)
According to the 24-hour chart, there is a support level at 12.13, which, if violated, would cause prices to drop to 11.66. In the upper region, resistance lies at 12.87. The next price resistance is at 13.14. RSI (Relative Strength Index) is 45.97 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.50, which suggests the price will decrease in the coming days. Percent R is at 70.04%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
